Fasting time and stomach volume for GLP-1 patients
Part of Digestive system clinical trials.
This trial studies how a longer fasting period affects stomach contents in people taking GLP-1 receptor agonists (a type of diabetes or weight-loss drug). It helps doctors understand if extra fasting time is needed before an upper endoscopy (a camera test for the stomach).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an elective (non-urgent) upper endoscopy with the gastroenterology team.
- You are currently taking a GLP-1 receptor agonist (like Ozempic, Wegovy, Mounjaro, etc.).
- You have not had an upper GI barium study in the last 24 hours.
- You do not have gastroparesis (delayed stomach emptying), achalasia, or pancreatitis.
- You are not using prescription pro-motility medications (drugs that help move food through your stomach).
- You are able to provide your own consent and agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study looks at how GLP-1 medications affect the time it takes for your stomach to empty before anesthesia. It may help doctors decide if you need to take special precautions before your surgery.
This study looks at whether people taking weekly GLP-1 medications (like Ozempic or Wegovy) should follow standard fasting rules or a 24-hour clear liquid diet before a procedure. The goal is to find the safest way to prepare.
This study looks at how long fasting and temporarily stopping certain diabetes or weight-loss medications (like semaglutide or liraglutide) affects how much food stays in your stomach. It may help understand how these medications work in people who are overweight.
This study looks at whether a common diabetes medication (GLP-1) affects how much food stays in your stomach before surgery. It aims to make anesthesia safer by understanding stomach content.
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Hear when a new GLP1-R-related Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.